<DOC>
	<DOCNO>NCT00138281</DOCNO>
	<brief_summary>Sixty adult , age 18-49 , randomly assign receive either FluMist Fluzone . Some subject participate previous study 2 vaccine . The study last 4 month subject participation 28 day . The purpose study measure immune response vaccination .</brief_summary>
	<brief_title>Influenza Immunity Against Pandemic Respiratory Virus</brief_title>
	<detailed_description>This Phase 4 , single-center , study immune response adults one two license influenza vaccine ( either inactivate vaccine give IM live , attenuated vaccine give intranasally ) . The study enroll 60 adult , age 18-49 , immunized Years 1 2 study . This study begin Year 1 grant protocol test two vaccine product age-approved population . FluMist approve use healthy child adolescent , 5-17 year age , healthy adult 18-49 year age . Fluzone approve age group start 6 month age . To match age study young child possible , age cohort 5-9 18-49 year choose initial Year 1 study . In 2003 , 70 adult 16 child enrol , randomize 1:1 receive either FluMist Fluzone immunize . In 2004 , 44 original 70 adult re-immunized preparation receive 2003 . In addition , study conduct twenty-eight 6mos 5yo child receive Fluzone thirty-nine 5-9 yo child randomize 1:1 receive either FluMist Fluzone . For 2005 , propose study protocol , adult last year agree third immunization plus many new adult add total 60 . Blood sample also take Days 0 , 7-9 28 analyzed CD4 CD8 T-cell , B-cell , NK-cell home receptor response .</detailed_description>
	<mesh_term>Influenza , Human</mesh_term>
	<criteria>1 . Healthy adult , age 1849 year participate Year 1 protocol . 2 . Willing sign inform consent . 3 . Availability followup plan duration study least 4 week immunization . 4 . Acceptable medical history screen evaluation brief clinical assessment . 5 . Negative urine serum pregnancy test woman childbearing potential . 6 . If subject female childbearing potential , must use acceptable contraception become pregnant duration study . ( Acceptable contraception include implant , injectables , combine oral contraceptive , effective intrauterine device ( IUDs ) , sexual abstinence , vasectomized partner ) . 1 . History immunodeficiency . 2 . Known suspected impairment immunologic function include , limited , clinically significant liver disease ; diabetes mellitus ; moderate severe kidney impairment . 3 . History GuillainBarr√© syndrome . 4 . Malignancy , squamous cell basal cell skin cancer . 5 . Autoimmune disease . 6 . History asthma reactive airway disease . 7 . Chronic cardiovascular pulmonary disorder . 8 . Chronic metabolic disease ( include diabetes ) , renal dysfunction hemoglobinopathy require regular medical followup hospitalization precede year . 9 . Use immunosuppressive medication . Corticosteroid nasal spray permissible . 10 . Medical psychiatric condition occupational responsibility preclude subject compliance protocol . 11 . Inactivated vaccine 14 day prior vaccination . 12 . Live , attenuate vaccine within 60 day study . 13 . Use investigational agent within 30 day prior study . 14 . Receipt blood product immunoglobulin past 6 month . 15 . Donation equivalent unit blood within 6 week prior enrollment . 16 . Acute febrile illness day vaccination . 17 . Pregnant lactating woman . 18 . Known allergy component vaccine , include thimerosal . 19 . History allergy egg egg product . 20 . Any condition , opinion investigator , might interfere study objective .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>49 Years</maximum_age>
	<verification_date>March 2010</verification_date>
	<keyword>influenza , vaccine , respiratory virus , Fluzone , FluMist</keyword>
</DOC>